Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04410445
Title Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence (PIVOT-12)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Nektar Therapeutics
Indications

skin melanoma

Therapies

Nivolumab

Nivolumab + NKTR-214

Age Groups: senior | adult | child
Covered Countries USA


No variant requirements are available.